Seizert Capital Partners LLC Invests $1.86 Million in Maximus, Inc. $MMS

Key Points

• Seizert Capital Partners acquired a new stake of 21,588 shares in Maximus in Q4, valued at about $1.86 million, while institutional investors now own roughly 97.21% of the company and several large funds (JPMorgan, Divisadero, Stephens, Dimensional) increased their positions.
• Brokerages have trimmed ratings recently, with Zacks, Weiss and Wall Street Zen cutting Maximus and the stock carrying a consensus Hold rating from analysts.
• Maximus slightly beat quarterly EPS expectations ($1.85 vs. $1.84) despite revenue falling 4.1%; it set FY2026 guidance of $8.05–$8.35 EPS, declared a $0.33 quarterly dividend (≈2.0% yield), and insiders including the CEO and CFO recently bought shares.

Seizert Capital Partners LLC acquired a new stake in Maximus, Inc. (NYSE:MMS - Free Report) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 21,588 shares of the health services provider's stock, valued at approximately $1,863,000.

Several other institutional investors and hedge funds have also recently modified their holdings of the company. JPMorgan Chase & Co. increased its stake in Maximus by 19.8% during the third quarter. JPMorgan Chase & Co. now owns 200,331 shares of the health services provider's stock worth $18,304,000 after purchasing an additional 33,136 shares during the period. Divisadero Street Capital Management LP boosted its stake in shares of Maximus by 93.5% in the third quarter. Divisadero Street Capital Management LP now owns 183,872 shares of the health services provider's stock valued at $16,800,000 after purchasing an additional 88,872 shares during the period. Stephens Investment Management Group LLC grew its holdings in shares of Maximus by 49.0% in the third quarter. Stephens Investment Management Group LLC now owns 720,943 shares of the health services provider's stock valued at $65,873,000 after purchasing an additional 237,097 shares in the last quarter. Dimensional Fund Advisors LP grew its holdings in shares of Maximus by 2.0% in the third quarter. Dimensional Fund Advisors LP now owns 1,869,573 shares of the health services provider's stock valued at $170,812,000 after purchasing an additional 36,989 shares in the last quarter. Finally, WINTON GROUP Ltd purchased a new stake in Maximus during the 3rd quarter worth approximately $6,208,000. Hedge funds and other institutional investors own 97.21% of the company's stock.

Analyst Upgrades and Downgrades

Several brokerages have commented on MMS. Zacks Research cut shares of Maximus from a "strong-buy" rating to a "hold" rating in a research report on Monday, April 27th. Weiss Ratings lowered Maximus from a "buy (b)" rating to a "hold (c+)" rating in a research report on Tuesday, February 24th. Finally, Wall Street Zen cut Maximus from a "buy" rating to a "hold" rating in a research note on Monday, February 23rd. Two research analysts have rated the stock with a Hold rating, Based on data from MarketBeat, the stock has a consensus rating of "Hold".

Maximus Stock Down 0.0%

Shares of Maximus stock opened at $65.55 on Monday. The company has a quick ratio of 2.34, a current ratio of 2.34 and a debt-to-equity ratio of 0.88. Maximus, Inc. has a 52-week low of $60.75 and a 52-week high of $100.00. The company has a market capitalization of $3.58 billion, a P/E ratio of 9.98 and a beta of 0.60. The company has a 50 day moving average of $69.28 and a 200 day moving average of $80.41.

Maximus (NYSE:MMS - Get Free Report) last announced its quarterly earnings data on Thursday, February 5th. The health services provider reported $1.85 EPS for the quarter, beating analysts' consensus estimates of $1.84 by $0.01. The company had revenue of $1.35 billion for the quarter, compared to the consensus estimate of $1.37 billion. Maximus had a net margin of 6.92% and a return on equity of 25.30%. The company's quarterly revenue was down 4.1% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.61 EPS. Maximus has set its FY 2026 guidance at 8.050-8.350 EPS. As a group, research analysts forecast that Maximus, Inc. will post 8.46 EPS for the current fiscal year.

Maximus Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, June 1st. Shareholders of record on Friday, May 15th will be paid a $0.33 dividend. The ex-dividend date is Friday, May 15th. This represents a $1.32 dividend on an annualized basis and a yield of 2.0%. Maximus's dividend payout ratio (DPR) is currently 20.09%.

Insiders Place Their Bets

In other Maximus news, CEO Bruce Caswell purchased 3,175 shares of the firm's stock in a transaction on Tuesday, February 10th. The stock was bought at an average cost of $78.45 per share, with a total value of $249,078.75. Following the acquisition, the chief executive officer directly owned 328,013 shares of the company's stock, valued at approximately $25,732,619.85. This represents a 0.98% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CFO David Mutryn purchased 1,000 shares of the firm's stock in a transaction on Monday, February 9th. The shares were acquired at an average cost of $75.62 per share, with a total value of $75,620.00. Following the completion of the acquisition, the chief financial officer directly owned 40,037 shares in the company, valued at $3,027,597.94. The trade was a 2.56% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. 1.80% of the stock is owned by company insiders.

Maximus Company Profile

Maximus, Inc NYSE: MMS is a global provider of government services focused on delivering health and human services programs. The company partners with federal, state, and local agencies to administer and manage programs that support individuals and families across various stages of life. Key service areas include eligibility determination and enrollment services for Medicaid, Medicare, Children's Health Insurance Program (CHIP) and other public assistance programs, as well as call center operations, case management and program integrity solutions.

Want to see what other hedge funds are holding MMS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Maximus, Inc. (NYSE:MMS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.